Tri-Air Developments

Tri-Air Developments is a UK-based medical technology company specializing in advanced air decontamination systems designed to eliminate airborne pathogens in healthcare and commercial environments. The company's proprietary Tri-Air technology utilizes a multi-stage process involving UV-C light, ozone, and a catalyst to generate hydroxyl radicals, which effectively neutralize bacteria, viruses, and fungi. Their systems are primarily deployed in hospitals to reduce the risk of hospital-acquired infections (HAIs) and improve overall air quality. Tri-Air's products have been validated through clinical trials and independent laboratory testing, demonstrating high efficacy against pathogens such as MRSA and Norovirus. The company focuses on providing continuous, non-invasive air purification that can operate safely in occupied spaces.